B. Yang et al. / Carbohydrate Polymers 92 (2013) 1308–1314
1313
Table 2
IC50 (mM) of SCU and SCU--CD conjugates in various colon cancer cell lines.
Cell line
Scutellarin (mM)
Amino-SCU--CD
Enamino-SCU--CD
Dienamino-SCU--CD
conjugate (mM)
conjugate (mM)
conjugate (mM)
HT-29
SW480
Lovo
0.30
0.21
0.078
0.16
0.15
0.052
0.045
0.076
0.048
0.039
0.034
0.077
0.046
0.057
0.048
HTC116
Zhang, Chen, Yu, & Liu, 2009). It has been known that during tumor
angiogenesis, the nascent capillaries supplying nutrients to the
tumors possess large gaps in between vascular endothelial cells
when compared to healthy tissues (Matsumura & Maeda, 1986).
The junction gap in the cancer cell membrane was loose, which
allowed conjugates to include cholesterols of the cell membrane.
So the conjugates tend to collect and accumulate in the interstitial
space of the tumor. With long amine linkage, the enamino-SCU--
CD and dienamino-SCU--CD conjugate could be inclined to insert
into the hydrophobic regions of the bilayers in result of easy anchor
at the loose bilayer of the cancer cell membrane. In the case of the
short amine linkage, amino-SCU--CD conjugate could not insert
into the hydrophobic regions of the bilayers. So the amino-SCU--
and dienamino-SCU--CD conjugate.
Foundation of Yunnan Province (No. 2009ZC045M), which are
gratefully acknowledged.
Appendix A. Supplementary data
Supplementary data associated with this article can be
References
Belanger, N., & Perly, B. (1992). NMR investigations of the conformation of a new
cyclodextrin-based amphiphilic transporter for hydrophobic drugs: Molecular
lollipops. Journal of Molecular Structure, 273, 215–226.
Croft, A. P., & Bartsch, R. A. (1983). Synthesis of chemically modified cyclodextrins.
Tetrahedron, 39, 1417–1474.
This supposition was also supported by the control experiments
with stained yeast cells by benzenesulfonamidoquinolino--
cyclodextrin (HQAS-1-CD and HQAS-2-CD, Fig. S8 a and b). As
yeast cells have many features analogous to mammalian cells, the
sion domains (Fig. S9 a and b), but most of the yeast cells did not
exhibit any appreciable fluorescence (see Supporting Information).
In addition, HQAS-1-CD showed poorer stained yeast cell pro-
gram than HQAS-2-CD (Liu et al., 2007; Zhang et al., 2009). This
phenomenon pointed that healthy cells which possess a compact
and integrated cell membrane had the ability to exclude conju-
gate molecule of cyclodextrin. The self-included conformation of
HQAS-2-CD also restricted the its interaction with cell membranes.
Therefore, HQAS-2-CD gave no response with healthy cells. How-
ever, with damaged cells, the junction gap in the cell membrane
increased, which allowed the -CD cavity of HQAS-2-CD to include
competitively exposed molecules of the cell membrane and anchor
in the loose bilayer of the cell. With long amine linkage, HQAS-2-CD
could be easy to insert into the hydrophobic regions of the bilayers
than HQAS-1-CD.
de Araújo, M. V. G., Vieira, E. K. B., Lázaro, G. S., Conegero, L. S., Almeida, L. E., Barreto, L.
S., et al. (2008). Sulfadiazine/hydroxypropyl--cyclodextrin host–guest system:
Characterization, phase-solubility and molecular modeling. Bioorganic Medicinal
& Chemistry, 16, 5788–5794.
Goh, D. Y., Lee, Y. H., & Ong, E. S. (2005). Inhibitory effects of a chemically stan-
dardized extract from Scutellaria barbata in human colon cancer cell lines, LoVo.
Journal of Agricultural and Food Chemistry, 53, 8197–8204.
Himeji, M., Ohtsuki, T., Fukazawa, H., Tanaka, M., Yazaki, S., Ui, S., et al. (2007). Differ-
ence of growth-inhibitory effect of Scutellaria baicalensis – producing flavonoid
wogonin among human cancer cells and normal diploid cell. Cancer Letters, 245,
269–274.
Hong, H., & Liu, G. Q. (2004). Protection against hydrogen peroxide-induced cyto-
toxicity in PC12 cells by scutellarin. Life Sciences, 74, 2959–2973.
Kamada, M., Hirayama, F., Udo, K., Yano, H., Arima, H., & Uekama, K. (2002).
Cyclodextrin conjugate-based controlled release system: Repeated- and
prolonged-releases of ketoprofen after oral administration in rats. Journal of
Controlled Release, 82, 407–416.
Li, H. X., Huang, D. Y., Gao, Z. X. Z., Lv, Y. H., Zhang, L. N., Cui, H. D., et al. (2010).
Scutellarin inhibits cell migrating by regulating production of ␣v6 integrin
and E-cadherin in human tongue. Oncology Reports, 24, 1153–1160.
Li-Weber, M. (2009). New therapeutic aspects of flavones: The anticancer properties
of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin.
Cancer Treatment Reviews, 35, 57–68.
Liu, Y., Zhang, N., Chen, Y., & Wang, L.-H. (2007). Fluorescence sensing and binding
behavior aminobenzenesulfonamidoquinolino--cyclodextrin to Zn2+. Organic
Letters, 9, 315–318.
Matsumura, Y., & Maeda, H. (1986). A new concept for macromolecular therapeutics
in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins
and the antitumor agent smancs. Cancer Research, 46, 6387–6392.
May, B. L., Kean, S. D., Easton, C. J., & Lincoln, S. F. (1997). Preparation and char-
acterization of 6A-polyamine-mono-substituted -cyclodextrins. Journal of the
Chemical Society, Perkin Transactions, 1, 3157–3160.
Montassier, P., Duchêne, D.,
& Poelman, M. C. (1997). Inclusion complexes
of tretinoin with cyclodextrins. International Journal of Pharmaceutics, 153,
199–209.
4. Conclusion
Petter, R. C., Salek, J. S., Sikorski, C. T., Kumaravel, G., & Lin, F. T. (1990). Cooperative
binding by aggregated mono-6-(alkylamino)-beta-cyclodextrins. Journal of the
American Chemical Society, 112, 3860–3868.
Szejtli, J. (1998). Introduction and general overview of cyclodextrin chemistry. Chem-
ical Reviews, 98, 1743–1753.
In conclusion, we successfully prepared a series of scutellarin-
-cyclodextrin conjugates (amino-SCU--CD conjugate, enamino-
SCU--CD conjugate and dienamino-SCU--CD conjugate), which
had much higher aqueous solubility than scutellarin, and could
hardly be hydrolyzed to scutellarin in aqueous solutions. The con-
jugates showed higher antiproliferative activities than free scutel-
larin. These valuable properties of the conjugates will enable their
potential application on new treatment for human colon cancer.
Udo, K., Hokonohara, K., Motoyama, K., Arima, H., Hirayama, F., & Uekama, K. (2010).
5-Fluorouracil acetic acid/-cyclodextrin conjugates: Drug release behavior
in enzymatic and rat cecal media. International Journal of Pharmaceutics, 388,
95–100.
Uekama, K., Minami, K., & Hirayama, F. (1997). 6A-O-[(4-Biphenylyl)-acetyl]-␣-, -
- and -␥-cyclodextrins and 6A-deoxy-6A-[[(4-biphenylyl)acetyl]amino]-␣-, -
- and -␥-cyclodextrins: Potential prodrugs for colon-specific delivery. Journal
of Medicinal Chemistry, 40, 2755–2761.
Wenz, G. (1994). Cyclodextrins as building blocks for supramolecular structures and
functional units. Angewandte Chemie International Edition, 33, 803–822.
Yang, B., Yang, L. J., Lin, J., Chen, Y., & Liu, Y. (2009). Binding behaviors of scutellarin
with ␣-, -␥-cyclodextrins and their derivatives. Journal of Inclusion Phenomena
and Macrocyclic Chemistry, 64, 149–155.
Acknowledgments
This work was supported by National Natural Science Foun-
dation of China (NNSFC) (No. 21062009) and the Natural Science